BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

139 related articles for article (PubMed ID: 2761662)

  • 1. [Multiple sclerosis: atrophy of the corpus callosum and psychosyndrome].
    Weihe W; Loew M; Schulze-Siedschlag J; Horstmann A; Welter FL; Mariss G
    Nervenarzt; 1989 Jul; 60(7):414-9. PubMed ID: 2761662
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Disseminated sclerosis: organic basis for mental disorders and cognitive dysfunction].
    Stenager E; Knudsen L; Jensen K
    Nord Med; 1991; 106(2):43-4, 49. PubMed ID: 2006091
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Cognitive and brain imaging measures of multiple sclerosis.
    Pozzilli C; Passafiume D; Anzini A; Borsellino G; Koudriavsteva T; Sarlo G; Fieschi C
    Ital J Neurol Sci; 1992 Dec; 13(9 Suppl 14):133-6. PubMed ID: 1345734
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Corpus callosum and subcallosal-periventricular lesions in multiple sclerosis: detection with MR.
    Simon JH; Holtås SL; Schiffer RB; Rudick RA; Herndon RM; Kido DK; Utz R
    Radiology; 1986 Aug; 160(2):363-7. PubMed ID: 3726114
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Clinical significance of corpus callosum atrophy in a mixed elderly population.
    Ryberg C; Rostrup E; Stegmann MB; Barkhof F; Scheltens P; van Straaten EC; Fazekas F; Schmidt R; Ferro JM; Baezner H; Erkinjuntti T; Jokinen H; Wahlund LO; O'brien J; Basile AM; Pantoni L; Inzitari D; Waldemar G;
    Neurobiol Aging; 2007 Jun; 28(6):955-63. PubMed ID: 16797787
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Volumetric reduction of the corpus callosum in Alzheimer's disease in vivo as assessed with voxel-based morphometry.
    Chaim TM; Duran FL; Uchida RR; Périco CA; de Castro CC; Busatto GF
    Psychiatry Res; 2007 Jan; 154(1):59-68. PubMed ID: 17174533
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Corpus callosum atrophy is associated with gait disorders in patients with leukoaraiosis.
    Moretti M; Carlucci G; Di Carlo A; Fonda C; Prieto M; Mugnai S; Bracco L; Piccini C; Pracucci G; Inzitari D
    Neurol Sci; 2005 Jun; 26(2):61-6. PubMed ID: 15995821
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Qualitative abnormal body sensations in multiple sclerosis].
    Wurthmann C; Daffertshofer M; Hennerici M
    Nervenarzt; 1990 Jun; 61(6):361-3. PubMed ID: 2377262
    [No Abstract]   [Full Text] [Related]  

  • 9. Psychosis in Apert's syndrome with partial agenesis of the corpus callosum.
    Gupta S; Popli A
    J Psychiatry Neurosci; 1995 Jul; 20(4):307-9. PubMed ID: 7647085
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Psychological and neuropsychological problems in multiple sclerosis].
    Béquet D; Taillia H; Clervoy P; Renard JL; Flocard F
    Bull Acad Natl Med; 2003; 187(4):683-94; discussion 695-7. PubMed ID: 14556476
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Cerebral transmission syndrome as an early symptom of multiple sclerosis. Nuclear magnetic resonance tomography and psychological test case study].
    Steller U; Beck U
    Nervenarzt; 1987 Apr; 58(4):256-60. PubMed ID: 3587459
    [No Abstract]   [Full Text] [Related]  

  • 12. Independent contributions of cortical gray matter atrophy and ventricle enlargement for predicting neuropsychological impairment in multiple sclerosis.
    Tekok-Kilic A; Benedict RH; Weinstock-Guttman B; Dwyer MG; Carone D; Srinivasaraghavan B; Yella V; Abdelrahman N; Munschauer F; Bakshi R; Zivadinov R
    Neuroimage; 2007 Jul; 36(4):1294-300. PubMed ID: 17524670
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Marchiafava-Bignami-like injury of the corpus callosum in an infant.
    Toelle SP; Huisman TA; Martin E; Boltshauser E
    Neuropediatrics; 2005 Oct; 36(5):328-31. PubMed ID: 16217709
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Brain atrophy and cognitive disorder in multiple sclerosis].
    Pál E; Kosztolányi P; Perlaky P
    Orv Hetil; 2002 Dec; 143(48):2681-5. PubMed ID: 12501577
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Quantitative determination of MS-induced corpus callosum atrophy in vivo using MR imaging.
    Simon JH; Schiffer RB; Rudick RA; Herndon RM
    AJNR Am J Neuroradiol; 1987; 8(4):599-604. PubMed ID: 3113196
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Atrophy of the corpus callosum, cognitive impairment, and cortical hypometabolism in progressive supranuclear palsy.
    Yamauchi H; Fukuyama H; Nagahama Y; Katsumi Y; Dong Y; Konishi J; Kimura J
    Ann Neurol; 1997 May; 41(5):606-14. PubMed ID: 9153522
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Differentiating multiple sclerosis from other causes of demyelination using diffusion weighted imaging of the corpus callosum.
    Straus Farber R; Devilliers L; Miller A; Lublin F; Law M; Fatterpekar G; Delman B; Naidich T
    J Magn Reson Imaging; 2009 Oct; 30(4):732-6. PubMed ID: 19787715
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Reduced area of the corpus callosum in posttraumatic stress disorder.
    Villarreal G; Hamilton DA; Graham DP; Driscoll I; Qualls C; Petropoulos H; Brooks WM
    Psychiatry Res; 2004 Sep; 131(3):227-35. PubMed ID: 15465292
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Corpus callosum atrophy--a simple predictor of multiple sclerosis progression: a longitudinal 9-year study.
    Vaneckova M; Kalincik T; Krasensky J; Horakova D; Havrdova E; Hrebikova T; Seidl Z
    Eur Neurol; 2012; 68(1):23-7. PubMed ID: 22677920
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Age-related MRI abnormalities in bipolar illness: a clinical study.
    Woods BT; Yurgelun-Todd D; Mikulis D; Pillay SS
    Biol Psychiatry; 1995 Dec; 38(12):846-7. PubMed ID: 8750046
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 7.